139 related articles for article (PubMed ID: 38049071)
1. Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativa.
Navrazhina K; Renert-Yuval Y; Khattri S; Hamade H; Meariman M; Andrews E; Kim M; NandyMazumdar M; Gour DS; Bose S; Williams SC; Garcet S; Correa da Rosa J; Gottlieb AB; Krueger JG; Guttman-Yassky E
J Am Acad Dermatol; 2024 Apr; 90(4):749-758. PubMed ID: 38049071
[TBL] [Abstract][Full Text] [Related]
2. Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis.
Guttman-Yassky E; Diaz A; Pavel AB; Fernandes M; Lefferdink R; Erickson T; Canter T; Rangel S; Peng X; Li R; Estrada Y; Xu H; Krueger JG; Paller AS
JAMA Dermatol; 2019 Dec; 155(12):1358-1370. PubMed ID: 31596431
[TBL] [Abstract][Full Text] [Related]
3. The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris.
Navrazhina K; Garcet S; Frew JW; Zheng X; Coats I; Guttman-Yassky E; Krueger JG
J Am Acad Dermatol; 2022 Feb; 86(2):322-330. PubMed ID: 34339761
[TBL] [Abstract][Full Text] [Related]
4. Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin.
Pavel AB; Renert-Yuval Y; Wu J; Del Duca E; Diaz A; Lefferdink R; Fang MM; Canter T; Rangel SM; Zhang N; Krueger JG; Paller AS; Guttman-Yassky E
Allergy; 2021 Jan; 76(1):314-325. PubMed ID: 32639640
[TBL] [Abstract][Full Text] [Related]
5. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression.
Navrazhina K; Garcet S; Zheng X; Hur HB; Frew JW; Krueger JG
J Allergy Clin Immunol; 2022 Jan; 149(1):135-144.e12. PubMed ID: 34081946
[TBL] [Abstract][Full Text] [Related]
6. Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasis.
He H; Bissonnette R; Wu J; Diaz A; Saint-Cyr Proulx E; Maari C; Jack C; Louis M; Estrada Y; Krueger JG; Zhang N; Pavel AB; Guttman-Yassky E
J Allergy Clin Immunol; 2021 Jan; 147(1):199-212. PubMed ID: 32709423
[TBL] [Abstract][Full Text] [Related]
7. Assessment of biomarkers in pediatric atopic dermatitis by tape strips and skin biopsies.
Andersson AM; Sølberg J; Koch A; Skov L; Jakasa I; Kezic S; Thyssen JP
Allergy; 2022 May; 77(5):1499-1509. PubMed ID: 34695223
[TBL] [Abstract][Full Text] [Related]
8. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.
Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP
Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173
[TBL] [Abstract][Full Text] [Related]
9. B-cell and complement signature in severe hidradenitis suppurativa that does not respond to adalimumab.
Hambly R; Gatault S; Smith CM; Iglesias-Martinez LF; Kearns S; Rea H; Marasigan V; Lynam-Loane K; Kirthi S; Hughes R; Fletcher JM; Kolch W; Kirby B
Br J Dermatol; 2023 Jan; 188(1):52-63. PubMed ID: 36689500
[TBL] [Abstract][Full Text] [Related]
10. Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape-strips and biopsies.
Del Duca E; He H; Liu Y; Pagan AD; David E; Cheng J; Carroll B; Renert-Yuval Y; Bar J; Estrada YD; Maari C; Proulx ES; Krueger JG; Bissonnette R; Guttman-Yassky E
Allergy; 2024 Jan; 79(1):80-92. PubMed ID: 37577841
[TBL] [Abstract][Full Text] [Related]
11. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa.
Saraç Öztürk G; Ergun T; Peker Eyüboğlu İ; Akkiprik M
Cytokine; 2021 Aug; 144():155585. PubMed ID: 34034145
[TBL] [Abstract][Full Text] [Related]
12. IL-17A is a pertinent therapeutic target for moderate-to-severe hidradenitis suppurativa: Combined results from a pre-clinical and phase II proof-of-concept study.
Kimball AB; Loesche C; Prens EP; Bechara FG; Weisman J; Rozenberg I; Jarvis P; Peters T; Roth L; Wieczorek G; Kolbinger F; Jemec GBE
Exp Dermatol; 2022 Oct; 31(10):1522-1532. PubMed ID: 35638561
[TBL] [Abstract][Full Text] [Related]
13. Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy.
Lowe MM; Naik HB; Clancy S; Pauli M; Smith KM; Bi Y; Dunstan R; Gudjonsson JE; Paul M; Harris H; Kim E; Shin US; Ahn R; Liao W; Hansen SL; Rosenblum MD
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32841223
[TBL] [Abstract][Full Text] [Related]
14. Primary alterations during the development of hidradenitis suppurativa.
Dajnoki Z; Somogyi O; Medgyesi B; Jenei A; Szabó L; Gáspár K; Hendrik Z; Gergely P; Imre D; Póliska S; Törőcsik D; Zouboulis CC; Prens EP; Kapitány A; Szegedi A
J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):462-471. PubMed ID: 34724272
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum.
Navrazhina K; Frew JW; Grand D; Williams SC; Hur H; Gonzalez J; Garcet S; Krueger JG
Br J Dermatol; 2022 Aug; 187(2):223-233. PubMed ID: 35191018
[TBL] [Abstract][Full Text] [Related]
16. Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers.
Vossen ARJV; van der Zee HH; Davelaar N; Mus AMC; van Doorn MBA; Prens EP
J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):761-765. PubMed ID: 30451329
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.
van der Zee HH; de Ruiter L; van den Broecke DG; Dik WA; Laman JD; Prens EP
Br J Dermatol; 2011 Jun; 164(6):1292-8. PubMed ID: 21332464
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Disease-Associated Pathways in Hidradenitis Suppurativa by the Janus Kinase 1 Inhibitor Povorcitinib: Transcriptomic and Proteomic Analyses of Two Phase 2 Studies.
Liu H; Santos LL; Smith SH
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108348
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis.
Rumberger BE; Boarder EL; Owens SL; Howell MD
Inflamm Res; 2020 Oct; 69(10):967-973. PubMed ID: 32661800
[TBL] [Abstract][Full Text] [Related]
20. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
van der Zee HH; Laman JD; de Ruiter L; Dik WA; Prens EP
Br J Dermatol; 2012 Feb; 166(2):298-305. PubMed ID: 22013960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
